Autoimmune Diseases
|
0.030 |
Biomarker
|
group |
BEFREE |
To provide a basis for the understanding of anti-amphiphysin autoimmunity, we have cloned cDNAs and determined the primary structure of human amphiphysin.
|
7757077 |
1995 |
Autoimmune Diseases of the Nervous System
|
0.010 |
Biomarker
|
group |
BEFREE |
Autoantibodies against amphiphysin occur in patients afflicted with a rare neurologic autoimmune disease, paraneoplastic Stiff-Man syndrome.
|
7757077 |
1995 |
Malignant Neoplasms
|
0.020 |
Biomarker
|
group |
BEFREE |
BIN1 is structurally related to amphiphysin, a breast cancer-associated autoimmune antigen, and RVS167, a negative regulator of the yeast cell cycle, suggesting roles in malignancy and cell cycle control.
|
8782822 |
1996 |
Primary malignant neoplasm
|
0.020 |
Biomarker
|
group |
BEFREE |
BIN1 is structurally related to amphiphysin, a breast cancer-associated autoimmune antigen, and RVS167, a negative regulator of the yeast cell cycle, suggesting roles in malignancy and cell cycle control.
|
8782822 |
1996 |
Autoimmune Diseases
|
0.030 |
AlteredExpression
|
group |
BEFREE |
Our study suggests a link between amphiphysin I expression in cancer and amphiphysin I autoimmunity.
|
9513187 |
1998 |
Malignant neoplasm of breast
|
0.030 |
Biomarker
|
disease |
BEFREE |
We report that amphiphysin I was expressed as two isoforms of 128 and 108 kD in the breast cancer of a patient with anti-amphiphysin I antibodies and paraneoplastic sensory neuronopathy.
|
9513187 |
1998 |
Breast Carcinoma
|
0.030 |
Biomarker
|
disease |
BEFREE |
We report that amphiphysin I was expressed as two isoforms of 128 and 108 kD in the breast cancer of a patient with anti-amphiphysin I antibodies and paraneoplastic sensory neuronopathy.
|
9513187 |
1998 |
Malignant Neoplasms
|
0.020 |
Biomarker
|
group |
BEFREE |
The enhanced expression of amphiphysin I in some forms of cancer supports the hypothesis that amphiphysin family members may play a role in the biology of cancer cells.
|
9513187 |
1998 |
Primary malignant neoplasm
|
0.020 |
Biomarker
|
group |
BEFREE |
The enhanced expression of amphiphysin I in some forms of cancer supports the hypothesis that amphiphysin family members may play a role in the biology of cancer cells.
|
9513187 |
1998 |
Cognition Disorders
|
0.010 |
Biomarker
|
group |
BEFREE |
Decreased synaptic vesicle recycling efficiency and cognitive deficits in amphiphysin 1 knockout mice.
|
11879655 |
2002 |
Impaired cognition
|
0.010 |
Biomarker
|
disease |
BEFREE |
Decreased synaptic vesicle recycling efficiency and cognitive deficits in amphiphysin 1 knockout mice.
|
11879655 |
2002 |
Lung Neoplasms
|
0.010 |
Biomarker
|
group |
LHGDN |
Antiamphiphysin-positive stiff-person syndrome associated with small cell lung cancer.
|
16671079 |
2006 |
Down Syndrome
|
0.010 |
PosttranslationalModification
|
disease |
BEFREE |
Phosphorylation of amphiphysin I by minibrain kinase/dual-specificity tyrosine phosphorylation-regulated kinase, a kinase implicated in Down syndrome.
|
16733250 |
2006 |
Complete Trisomy 21 Syndrome
|
0.010 |
PosttranslationalModification
|
disease |
BEFREE |
Phosphorylation of amphiphysin I by minibrain kinase/dual-specificity tyrosine phosphorylation-regulated kinase, a kinase implicated in Down syndrome.
|
16733250 |
2006 |
Myopathy, Centronuclear, Autosomal Recessive
|
0.020 |
GeneticVariation
|
disease |
BEFREE |
Mutations in amphiphysin 2 (BIN1) disrupt interaction with dynamin 2 and cause autosomal recessive centronuclear myopathy.
|
17676042 |
2007 |
Autosomal Recessive Centronuclear Myopathy
|
0.020 |
GeneticVariation
|
disease |
BEFREE |
Mutations in amphiphysin 2 (BIN1) disrupt interaction with dynamin 2 and cause autosomal recessive centronuclear myopathy.
|
17676042 |
2007 |
Gastrointestinal Stromal Tumors
|
0.010 |
Biomarker
|
group |
BEFREE |
Expression of synaptic-like microvesicle proteins, e.g., Synaptic vesicle protein 2 (SV2), synaptobrevin, synapsin 1, and amphiphysin was demonstrated in a majority of GISTs by immunohistochemistry, western blotting, and quantitative reversetranscriptase PCR.
|
17914114 |
2007 |
Lymphoma, Follicular
|
0.010 |
Biomarker
|
disease |
BEFREE |
Combined Bisulfite Restriction Analysis (COBRA) also established DNA methylation for the previously identified PRC2 targets DCC, DES, GAD2, AQP5, GPR61, GRIA4, GJD2, and AMPH in FL but not in BFH.
|
19530241 |
2009 |
Centronuclear myopathy
|
0.060 |
GeneticVariation
|
disease |
BEFREE |
Mutations in dynamin 2 and amphiphysin 2 genes lead to autosomal forms of centronuclear myopathy (CNM).
|
20434914 |
2010 |
Centronuclear myopathy
|
0.060 |
GeneticVariation
|
disease |
BEFREE |
Defects in amphiphysin 2 (BIN1) and triads in several forms of centronuclear myopathies.
|
20927630 |
2011 |
Myopathy, Centronuclear, Autosomal Recessive
|
0.020 |
GeneticVariation
|
disease |
BEFREE |
Autosomal recessive centronuclear myopathy (ARCNM) is less characterized and has recently been associated to mutations in BIN1, encoding amphiphysin 2.
|
21129173 |
2010 |
Autosomal Recessive Centronuclear Myopathy
|
0.020 |
GeneticVariation
|
disease |
BEFREE |
Autosomal recessive centronuclear myopathy (ARCNM) is less characterized and has recently been associated to mutations in BIN1, encoding amphiphysin 2.
|
21129173 |
2010 |
Esophageal Neoplasms
|
0.100 |
GeneticVariation
|
group |
GWASDB |
Genome-wide association analyses of esophageal squamous cell carcinoma in Chinese identify multiple susceptibility loci and gene-environment interactions.
|
22960999 |
2012 |
Alzheimer's Disease
|
0.020 |
Biomarker
|
disease |
BEFREE |
The AMPH1 protein reduction was validated in Alzheimer's disease cases.
|
22975846 |
2012 |
Centronuclear myopathy
|
0.060 |
Biomarker
|
disease |
BEFREE |
Our data demonstrate that the alteration of the muscle-specific function of amphiphysin 2 is a common pathomechanism for centronuclear myopathy, myotonic dystrophy, and IMGD.
|
23754947 |
2013 |